Evidence map›Paper›PMID 35163021›Full record

ReviewInternational journal of molecular sciences2022

Opioids and Sepsis: Elucidating the Role of the Microbiome and microRNA-146.

Yaa Abu, Nicolas Vitari, Yan Yan, Sabita Roy

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yaa AbuMedical Scientist Training Program, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Nicolas VitariDepartment of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Yan YanDepartment of Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Sabita RoyDepartment of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
University of Miami · US

Funding

Opioid Abuse, opportunistic infection and NeuroAIDSR01DA012104 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ROY, SABITA · 1999 to 2013
$3.7M
Role of Microbial dysbiosis and altered metabolomics in the context of Opioid abuse and ART in HIV disease progressionR01DA043252 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ROY, SABITA · 2017 to 2021
$3.0M
Gut microbiota disruption by Morphine and in the context of HIV infection contributes to sustained immune activationR01DA037843 · NIDA · UNIVERSITY OF MINNESOTA · PI JOHNSON, TIMOTHY J, ROY, SABITA · 2014 to 2018
$2.8M
Microbial Dysbiosis and TLR2 Activation Contribute to Immune Activation, Inflammation and HIV Persistence in the Context of Opioid Abuse Despite ART TherapyR01DA044582 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ROY, SABITA · 2017 to 2021
$2.6M
Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV R01DA050542 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ROY, SABITA · 2019 to 2023
$2.5M
Role of Gut Microbiome in HIV/Opioid Induced Peripheral NeuropathyR01DA047089 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HAO, SHUANGLIN, RAMAKRISHNAN, SUNDARAM · 2018 to 2022
$2.3M
The Role of Microbiome Modulation in Morphine-Induced Exacerbation of PancreatitisR01DK117576 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ROY, SABITA · 2018 to 2021
$2.0M
Mechanism underlying Morphine modulation of gut barrier function in the Context oR01DA034582 · NIDA · UNIVERSITY OF MINNESOTA · PI ROY, SABITA · 2013 to 2017
$1.6M
NIDA NIH HHS R01 DA012104NIDA NIH HHS R01 DA034582NIDA NIH HHS R01 DA047089NIDDK NIH HHS R01 DK117576NIH HHS R01 DA037843NIH HHS R01 DA043252NIH HHS R01 DA044582NIH HHS R01 DA047089NIH HHS R01 DA050542
6 · The paper itself

Abstract

Sepsis has recently been defined as life-threatening organ dysfunction caused by the dysregulated host response to an ongoing or suspected infection. To date, sepsis continues to be a leading cause of morbidity and mortality amongst hospitalized patients. Many risk factors contribute to development of sepsis, including pain-relieving drugs like opioids, which are frequently prescribed post-operatively. In light of the opioid crisis, understanding the interactions between opioid use and the development of sepsis has become extremely relevant, as opioid use is associated with increased risk of infection. Given that the intestinal tract is a major site of origin of sepsis-causing microbes, there has been an increasing focus on how alterations in the gut microbiome may predispose towards sepsis and mediate immune dysregulation. MicroRNAs, in particular, have emerged as key modulators of the inflammatory response during sepsis by tempering the immune response, thereby mediating the interaction between host and microbiome. In this review, we elucidate contributing roles of microRNA 146 in modulating sepsis pathogenesis and end with a discussion of therapeutic targeting of the gut microbiome in controlling immune dysregulation in sepsis.

Indexed as

Gastrointestinal MicrobiomeImmunityAnalgesics, OpioidHumansMicroRNAsProbioticsSepsisAnalgesics, OpioidMicroRNAsMIRN146 microRNA, humanendotoxininflammationmicrobiomemiR-146miRNAopioidssepsis

Identifiers

PMID35163021
PMCPMC8835205
OpenAlexW4205395879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.